Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Other Operating Expenses (2020 - 2025)

INVO Fertility (IVF) has disclosed Other Operating Expenses for 7 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • Quarterly Other Operating Expenses changed N/A to $1.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Sep 2025, up 422.29% year-over-year, with the annual reading at $94551.0 for FY2024, 100.84% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $1.2 million at INVO Fertility, down from $2.5 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $15.9 million in Q1 2025, with the low at -$6.2 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $716104.8, with a median of $46060.0 recorded in 2021.
  • The sharpest move saw Other Operating Expenses tumbled 84525.46% in 2022, then skyrocketed 16710.37% in 2025.
  • Over 5 years, Other Operating Expenses stood at -$11432.0 in 2021, then skyrocketed by 3276.89% to $363182.0 in 2022, then crashed by 1802.99% to -$6.2 million in 2023, then surged by 101.53% to $94551.0 in 2024, then skyrocketed by 1204.16% to $1.2 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $1.2 million, $2.5 million, and $15.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.